EAY191-S3 ComboMATCH

The purpose of this study is to determine the effectiveness of Paclitaxel and Ipatasertib in patients who progressed within 6 months of taxane-based therapy. You must have a a AKT-Altered cancer. You must have a locally advanced, unresectable or metastatic cancer.
Contact phone
Tera Williams | 517.364.2910
Contact email
Principal investigator
Dr. Gordan Srkalovic, MD, PhD
Trial Category
Trial SubCategory
Solid Tumors (non-breast)